Anemia and transfusion after subarachnoid hemorrhage

Neurocritical Care

Volumn 15, Issue 2, 2011, Pages 342-353

  Le Roux, Peter D ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Anemia; Erythropoietin; Oxygen delivery; Vasospasm

Indexed keywords

ERYTHROPOIETIN; HEMOGLOBIN; PLACEBO;

ANEMIA; ANEURYSM RUPTURE; BLOOD TRANSFUSION REACTION; BRAIN BLOOD FLOW; BRAIN ISCHEMIA; BRAIN PERFUSION; BRAIN VASCULAR RESISTANCE; BRAIN VASOSPASM; CENTRAL VENOUS PRESSURE; DELAYED CEREBRAL ISCHEMIA; DISEASE ASSOCIATION; DISEASE EXACERBATION; DISEASE SEVERITY; ELECTROENCEPHALOGRAM; ERYTHROCYTE TRANSFUSION; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPOXIA; OXYGEN CONSUMPTION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK FACTOR; SUBARACHNOID HEMORRHAGE; SYSTEMATIC REVIEW; TISSUE OXYGENATION; TRAUMATIC BRAIN INJURY; TREATMENT OUTCOME; ACUTE DISEASE; BLOOD TRANSFUSION; INTENSIVE CARE; METHODOLOGY;

ACUTE DISEASE; ANEMIA; BLOOD TRANSFUSION; CRITICAL CARE; HUMANS; SUBARACHNOID HEMORRHAGE; VASOSPASM, INTRACRANIAL;

EID: 84855876870     PISSN: 15416933     EISSN: 15560961     Source Type: Journal    
DOI: 10.1007/s12028-011-9582-z     Document Type: Review

References (112)

1. ACROSS Group. Epidemiology of aneurysmal subarachnoid hemorrhage in Australia and New Zealand: Incidence and case fatality from the Australasian Cooperative Research on Subarachnoid Hemorrhage Study (ACROSS). Stroke. 2000;31: 1843-50.
2. Ingall T, Asplund K, Mahonen M, Bonita R. A multinational comparison of subarachnoid hemorrhage epidemiology in the WHO MONICA stroke study. Stroke. 2000;31:1054-61. (Pubitemid 30253525)
3. Broderick JP, Thomas GB, Dudler JE, Tomsick T, Leach A. Initial and recurrent bleeding are the major causes of death following subarachnoid hemorrhage. Stroke. 1994;25:1342-7. (Pubitemid 24198577)
4. Fogelholm R, Hernesniemi J, Vapalahti M. Impact of early surgery on outcome after aneurysmal subarachnoid hemorrhage: A population-based study. Stroke. 1993;24:1649-54. (Pubitemid 23315869)
5. Le Roux P, Winn HR. Management of the ruptured aneurysm. In: Le Roux P, Winn HR, Newell DW, editors. Management of cerebral aneurysms. Philadelphia: Elsevier; 2004. p. 303-33.
6. Kreiter KT, Copeland D, Bernardini GL, et al. Predictors of cognitive dysfunction after subarachnoid hemorrhage. Stroke. 2002;33:200-8. (Pubitemid 34052210)
7. Ogden JA, Mee EW, Henning M. A prospective study of impairment of cognition and memory and recovery after subarachnoid hemorrhage. Neurosurgery. 1993;33:572-87. (Pubitemid 23292748)
8. Ropper AH, Zervas NT. Outcome one year after SAH from cerebral aneurysm. Management morbidity, mortality and functional status in 112 consecutive good risk patients. J Neurosurg. 1984;60:909-15. (Pubitemid 14134793)
9. Tidswell P, Dias PS, Sagar HJ, Mayes AR, D Phil, Battersby RDE. Cognitive outcome after aneurysm rupture: Relationship to aneurysm site and perioperative complications. Neurology 1995;45:875-82.
10. Scharbrodt W, Stein M, Schreiber V, Böker DK, Oertel MF. The prediction of long-term outcome after subarachnoid hemorrhage as measured by the Short Form-36 Health Survey. J Clin Neurosci. 2009;16:1409-13.
11. Claassen J, Vu A, Kreiter KT, et al. Effect of acute physiologic derangements on outcome after subarachnoid hemorrhage. Crit Care Med. 2004;32:832-8. (Pubitemid 38344142)
12. Gruber A, Reinprecht A, Illievich UM, et al. Extracerebral organ dysfunction and neurologic outcome after aneurysmal subarachnoid hemorrhage. Crit Care Med. 1999;27:505-14. (Pubitemid 29162670)
13. Le Roux PD, Elliott JP, Downey L, et al. Improved outcome after rupture of anterior circulation aneurysms: A retrospective 10-year review of 224 good-grade patients. J Neurosurg. 1995;83:394-402.
14. Le Roux PD, Elliott JP, Newell D, et al. Predicting outcome in poor grade patients with subarachnoid hemorrhage: A review of 159 aggressively managed cases. J Neurosurg. 1996;85:39-49. (Pubitemid 26195036)
15. Bederson JB, Connolly ES Jr, Batjer HH, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage: A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke. 2009;40:994-1025.
16. Naidech AM, Janjua N, Kreiter KT, et al. Predictors and impact of aneurysm rebleeding after subarachnoid hemorrhage. Arch Neurol. 2005;62:410-6. (Pubitemid 40349476)
17. Schuiling WJ, Dennesen PJ, Rinkel GJ. Extracerebral organ dysfunction in the acute stage after aneurysmal subarachnoid hemorrhage. Neurocrit Care. 2005;3:1-10. (Pubitemid 41278386)
18. Solenski N, Haley C, Kassell NF, et al. Medical complications of aneurysmal subarachnoid hemorrhage: A report of the multicenter, cooperative aneurysm study. Crit Care Med. 1995;23:1007-17.
19. Wartenberg KE, Schmidt JM, Claassen J, et al. Impact of medical complications on outcome after subarachnoid hemorrhage. Crit Care Med. 2006;34:617-23.
20. Kassell NF, Torner JC, Haley EC Jr, Jane JA, Adams HP, Kongable GL. The international cooperative study on the timing of aneurysm surgery. Part 1: Overall management results. J Neurosurg. 1990;73:18-36. (Pubitemid 20206379)
21. Jahromi BS, MacDonald RL. Vasospasm: Diagnosis and medical management. In: Le Roux P, Winn HR, Newell DW, editors. Management of cerebral aneurysms. Philadelphia: Elsevier; 2004. p. 455-87.
22. Dorsch NWC, King MT. A review of cerebral vasospasm in aneurysmal subarachnoid hemorrhage. Part 1: Incidence and effects. J Clin Neurosci. 1994;1:19-26.
23. Haley EC Jr, Kassell NF, Apperson-Hansen C, Maile MH, Alves WM. A randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneuriymal subarachnoid hemorrhage: A cooperative study in North America. J Neurosurg. 1997;86:467-74. (Pubitemid 27097093)
24. Lanzino G, Kassell NJ. Double-blind, randomized, vehiclecontrolled study of high-dose tirilazad mesylate in women with aneurysmal subarachnoid hemorrhage. Part II. A cooperative study in North America. J Neurosurg. 1999;90:1018-24. (Pubitemid 29241167)
25. Macdonald RL, Kassell NF, Mayer S, et al. Clazosentan to overcome neurological ischemia and infarction occurring after subarachnoid hemorrhage (CONSCIOUS-1): Randomized, double- blind, placebo-controlled phase 2 dose-finding trial. Stroke. 2008;39:3015-21.
26. Kreiter KT, Mayer SA, Howard G, Knappertz V, Ilodigwe D, Sloan MA, Macdonald RL. Sample size estimates for clinical trials of vasospasm in subarachnoid hemorrhage. Stroke. 2009;40:2362-7.
27. Sampson TR, Dhar R, Diringer MN. Factors associated with the development of anemia after subarachnoid hemorrhage. Neurocrit Care. 2010;12:4-9.
28. Giller CA, Wills MJ, Giller AM, Samson D. Distribution of hematocrit values after aneurysmal subarachnoid hemorrhage. J Neuroimag. 1998;8:169-70. (Pubitemid 28311660)
29. Kramer AH, Gurka MJ, Nathan B, Dumont AS, Kassell NF, Bleck TP. Complications associated with anemia and blood transfusion in patients with aneurysmal subarachnoid hemorrhage. Crit Care Med. 2008;36:2070-5.
30. Naidech AM, Jovanovic B, Wartenberg KE, et al. Higher hemoglobin is associated with improved outcome after subarachnoid hemorrhage. Crit Care Med. 2007;35:2383-9. (Pubitemid 47476238)
31. Naidech AM, Drescher J, Ault ML, Shaibani A, Batjer HH, Alberts MJ. Higher hemoglobin is associated with less cerebral infarction, poor outcome, and death after subarachnoid hemorrhage. Neurosurgery. 2006;59:775-80.
32. Hebert PC, Wells G, Blajchman MA, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 1999;340:409-17 (Pubitemid 29084771)
33. Erratum in: N Engl J Med 1999;340:1056).
34. Malone DL, Dunne J, Tracy JK, Putnam AT, Scalea TM, Napolitano LM. Blood transfusion, independent of shock severity, is associated with worse outcome in trauma. J Trauma. 2003;54:898-905.
35. Moore FA, Moore EE, Sauaia A. Blood transfusion: An independent risk factor for postinjury multiple organ failure. Arch Surg. 1997;132:620-5. (Pubitemid 27255607)
36. Marik PE, Corwin HL. Efficacy of red blood cell transfusion in the critically ill: A systematic review of the literature. Crit Care Med. 2008;36:2667-74.
37. Marik PE, Sibbald WJ. Effect of stored-blood transfusion on oxygen delivery in patients with sepsis. JAMA. 1993;269: 3024-9. (Pubitemid 23164346)
38. Gow AJ, Stamler JS. Reactions between nitric oxide and haemoglobin under physiological conditions. Nature. 1998;391: 169-73. (Pubitemid 28092474)
39. Fransen E, Maessen J, Senden N, et al. Impact of blood transfusions on inflammatory mediator release in patients undergoing cardiac surgery. Chest. 1999;116:1233-9. (Pubitemid 29535973)
40. Blajchman MA. Transfusion-associated immunomodulation and universal white cell reduction: Are we putting the cart before the horse? Transfusion. 1999;39:665-70. (Pubitemid 29328476)
41. Berezina TL, Zaets SB, Morgan C, et al. Influence of storage on red blood cell rheological properties. J Surg Res. 2002;102: 6-12.
42. Stamler JS, Jia L, Eu JP, et al. Blood flow regulation by S-nitrosohemoglobin in the physiological oxygen gradient. Science. 1997;276:2034-7. (Pubitemid 27443606)
43. Dumont AS, Dumont RJ, Chow MM, et al. Cerebral vasospasm after subarachnoid hemorrhage: Putative role of inflammation. Neurosurgery. 2003;53:123-33.
44. Atkins D, Best D, Briss PA, et al. Grading quality of evidence and strength of recommendations. BMJ. 2004;328:1490.
45. Smith MJ, Maggee S, Stiefel M, Bloom S, Gracias V, Le Roux P. Packed red blood cell transfusion increases local cerebral oxygenation. Crit Care Med. 2005;33:1104-8. (Pubitemid 40638186)
46. Leal-Noval SR, Rincón-Ferrari MD, Marin-Niebla A, et al. Transfusion of erythrocyte concentrates produces a variable increment on cerebral oxygenation in patients with severe traumatic brain injury: A preliminary study. Intensive Care Med. 2006;32:1733-40. (Pubitemid 44607360)
47. Leal-Noval SR, Muñoz-Gómez M, Arellano-Orden V, et al. Impact of age of transfused blood on cerebral oxygenation in male patients with severe traumatic brain injury. Crit Care Med. 2008;36:1290-6. (Pubitemid 351482680)
48. Zygun DA, Nortje J, Hutchinson PJ, Timofeev I, Menon DK, Gupta AK. The effect of red blood cell transfusion on cerebral oxygenation and metabolism after severe traumatic brain injury. Crit Care Med. 2009;37:1074-8.
49. Figaji AA, Zwane E, Kogels M, et al. The effect of blood transfusion on brain oxygenation in children with severe traumatic brain injury. Pediatr Crit Care Med. 2010;11:325-31.
50. Ekelund A, Reinstrup P, Ryding E, et al. Effects of iso- and hypervolemic hemodilution on regional cerebral blood flow and oxygen delivery for patients with vasospasm after aneurysmal subarachnoid hemorrhage. Acta Neurochir (Wien). 2002; 144:703-12.
51. Muench E, Horn P, Bauhuf C, Roth H, Philipps M, Hermann P, Quintel M, Schmiedek P, Vajkoczy P. Effects of hypervolemia and hypertension on regional cerebral blood flow, intracranial pressure, and brain tissue oxygenation after subarachnoid hemorrhage. Crit Care Med. 2007;35:1844-51. (Pubitemid 47220357)
52. Dhar R, Zazulia AR, Videen TO, Zipfel GJ, Derdeyn CP, Diringer MN. Red blood cell transfusion increases cerebral oxygen delivery in anemic patients with subarachnoid hemorrhage. Stroke. 2009;40:3039-44.
53. Naidech AM, Bendok BR, Ault ML, Bleck TP. Monitoring with the Somanetics INVOS 5100C after aneurysmal subarachnoid hemorrhage. Neurocrit Care. 2008;9:326-31.
54. Oddo M, Milby A, Chen I, et al. Hemoglobin concentration and cerebral metabolism in patients with aneurysmal subarachnoid hemorrhage: A microdialysis study. Stroke. 2009;40:1275-81.
55. Kurtz P, Schmidt JM, Claassen J, et al. Anemia is associated with metabolic distress and brain tissue hypoxia after subarachnoid hemorrhage. Neurocrit Care. 2010;13:10-6.
56. Kramer AH, Zygun DA, Bleck TP, Dumont AS, Kassell NF, Nathan B. Relationship between hemoglobin concentrations and outcomes across subgroups of patients with aneurysmal subarachnoid hemorrhage. Neurocrit Care. 2009;10:157-65.
57. Wartenberg KE, Mayer SA. Medical complications after subarachnoid hemorrhage: New strategies for prevention and management. Curr Opin Crit Care. 2006;12:78-84.
58. Levine J, Kofke A, Cen L, Chen Z, Elliott JP, Winn HR, Le Roux P. Red blood cell transfusion is associated with medical complications after subarachnoid hemorrhage. Neurosurgery. 2010;66:312-8.
59. Naidech AM, Shaibani A, Garg RK, et al. Prospective, randomized trial of higher goal hemoglobin after subarachnoid hemorrhage. Neurocrit Care. 2010;13:313-20.
60. Broessner G, Lackner P, Hoefer C, et al. Influence of red blood cell transfusion on mortality and long-term functional outcome in 292 patients with spontaneous subarachnoid hemorrhage. Crit Care Med. 2009;37:1886-92.
61. Springer MV, Schmidt JM, Wartenberg KE, Frontera JA, Badjatia N, Mayer SA. Predictors of global cognitive impairment 1 year after subarachnoid hemorrhage. Neurosurgery. 2009;65:1043-50.
62. Tseng MY, Hutchinson PJ, Kirkpatrick PJ. Effects of fluid therapy following aneurysmal subarachnoid haemorrhage: A prospective clinical study. Br J Neurosurg. 2008;22:257-68. (Pubitemid 351414904)
63. Smith MJ, Le Roux PD, Elliott JP, Winn HR. Blood transfusion and increased risk for vasospasm and poor outcome after subarachnoid hemorrhage. J Neurosurg. 2004;101:1-7. (Pubitemid 38808453)
64. Tseng MY, Hutchinson PJ, Kirkpatrick PJ. Interaction of neurovascular protection of erythropoietin with age, sepsis, and statin therapy following aneurysmal subarachnoid hemorrhage. J Neurosurg. 2010;112:1235-9.
65. Tseng MY, Hutchinson PJ, Richards HK, et al. Acute systemic erythropoietin therapy to reduce delayed ischemic deficits following aneurysmal subarachnoid hemorrhage: A Phase II randomized, double-blind, placebo-controlled trial. J Neurosurg. 2009;111:171-80.
66. Springborg JB, Møller C, Gideon P, Jørgensen OS, Juhler M, Olsen NV. Erythropoietin in patients with aneurysmal subarachnoid haemorrhage: A double blind randomised clinical trial. Acta Neurochir (Wien). 2007;149:1089-101.
67. Springborg JB, Sonne B, Frederiksen HJ, et al. Erythropoietin in the cerebrospinal fluid of patients with aneurysmal subarachnoid haemorrhage originates from the brain. Brain Res. 2003;984:143-8. (Pubitemid 36976803)
68. Kramer AH, Zygun DA. Anemia and red blood cell transfusion in neurocritical care. Crit Care. 2009;13:R89.
69. Tseng MY, Hutchinson PJ, Czosnyka M, Richards H, Pickard JD, Kirkpatrick PJ. Effects of acute pravastatin treatment on intensity of rescue therapy, inpatient hospital stay and sixmonth outcome in patients after aneurhemorrhage. Stroke. 2007;38:1545-50. (Pubitemid 46684172)
70. Hare GM, Mazer CD, Mak W, et al. Hemodilutional anemia is associated with increased cerebral neuronal nitric oxide synthase gene expression. J Appl Physiol. 2003;94:2058-67. (Pubitemid 36457460)
71. Johannson H, Siesjo BK. Brain energy metabolism in anesthetized rats in acute anemia. Acta Physiol Scand. 1975;93:515-24.
72. Dexter F, Hindman BJ. Effect of haemoglobin concentration on brain oxygenation in focal stroke: A mathematical modelling study. Br J Anaesth. 1997;79:346-51. (Pubitemid 27404050)
73. Borgstrom L, Johannsson H, Siesjo BK. The influence of acute normovolemic anemia on cerebral blood flow and oxygen consumption of anesthetized rats. Acta Physiol Scand. 1975; 93:505-14.
74. McLaren AT, Marsden PA, Mazer CD, et al. Increased expression of hif-1alpha, nnos, and vegf in the cerebral cortex of anemic rats. Am J Physiol Regul Integr Comp Physiol. 2007;292:R403-14. (Pubitemid 46089855)
75. Corwin HL, Gettinger A, Pearl RG, et al. Anemia and blood transfusion in the critically ill-current clinical practice in the United States. Crit Care Med. 2004;32:39-52. (Pubitemid 38125561)
76. Napolitano LM, Kurek S, Luchette FA, et al. Clinical practice guideline: Red blood cell transfusion in adult trauma and critical care. Crit Care Med. 2009;37:3124-57.
77. Russell JA, Phang PT. The oxygen delivery/consumption controversy: An approach to management of the critically ill. Am J Respir Crit Care Med. 1994;149:533-7. (Pubitemid 24069008)
78. Palmieri TL, Caruso DM, Foster KN, et al. Effect of blood transfusion on outcome after major burn injury: A multicenter study. Crit Care Med. 2006;34:1602-7. (Pubitemid 43810037)
79. Taylor RW, Manganaro L, O'Brien J, et al. Impact of allogenic packed red blood cell transfusion on nosocomial infection rates in the critically ill patient. Crit Care Med. 2002;30:2249-54. (Pubitemid 35191575)
80. Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ. The risk of transfusion-transmitted viral infections. N Engl J Med. 1996;334:1685-90. (Pubitemid 26193619)
81. Koch CG, Li L, Duncan AI, et al. Morbidity and mortality risk associated with red blood cell and blood-component transfusion in isolated coronary artery bypass grafting. Crit Care Med. 2006;34:1608-16. (Pubitemid 43810038)
82. Hill GE, Frawley WH, Griffith KE, Forestner JE, Minei JP. Allogeneic blood transfusion increases the risk of postoperative bacterial infection: A meta-analysis. J Trauma. 2003;54:908-14. (Pubitemid 36758801)
83. Shorr AF, Duh MS, Kelly KM, Kollef MH, CRIT study group. Red blood cell transfusion and ventilator-associated pneumonia: A potential link? Crit Care Med. 2004;32:666-74. (Pubitemid 38340061)
84. Earley AS, Gracias VH, Haut E, et al. Anemia management program reduces transfusion volumes, incidence of ventilatorassociated pneumonia, and cost in trauma patients. J Trauma. 2006;61:1-5. (Pubitemid 44098304)
85. Gong MN, Thompson BT, Williams P, et al. Clinical predictors of and mortality in acute respiratory distress syndrome: Potential role of red cell transfusion. Crit Care Med. 2005;33:1191-8. (Pubitemid 40827364)
86. Zilberberg MD, Carter C, Lefebvre P, et al. Red blood cell transfusions and the risk of acute respiratory distress syndrome among the critically ill: A cohort study. Crit Care. 2007;11:R63.
87. Sauaia A, Moore FA, Moore EE, et al. Early predictors of postinjury multiple organ failure. Arch Surg. 1994;129:39-45. (Pubitemid 24024516)
88. Ranucci M, Pavesi M, Mazza E, et al. Risk factors for renal dysfunction after coronary surgery: The role of cardiopulmonary bypass technique. Perfusion. 1994;9:319-26. (Pubitemid 24308136)
89. Ciesla DJ, Moore EE, Johnson JL, Burch JM, Cothren CC, Sauaia A. A 12-year prospective study of postinjury multiple organ failure: Has anything changed? Arch Surg. 2005; 140:432-8.
90. Vincent JL, Baron J-F, Reinhart K, Gattinoni L, Thijs L, Webb A, et al. Anemia and blood transfusion in critically ill patients. J Am Med Assoc. 2002;288:1499-507.
91. Ho J, Sibbald WJ, Chin-Yee IH. Effects of storage on efficacy of red cell transfusion: When is it not safe? Crit Care Med. 2003;31(12 Suppl):S687-97. (Pubitemid 38010656)
92. Lacroix J, Hebert PC, Hutchison JS, et al. Transfusion strategies for patients in pediatric intensive care units. N Engl J Med. 2007;356:1609-19. (Pubitemid 46631670)
93. Sena MJ, Rivers RM, Muizelaar JP, Battistella FD, Utter GH. Transfusion practices for acute traumatic brain injury: A survey of physicians at US trauma centers. Intensive Care Med. 2009;35:480-8.
94. Wu WC, Rathore SS, Wang Y, Radford MJ, Krumholz HM. Blood transfusion in elderly patients with acute myocardial infarction. N Engl J Med. 2001;345:1230-6. (Pubitemid 34951486)
95. Aronson D, Dann EJ, Bonstein L, et al. Impact of RBC transfusion on clinical outcomes in patients with acute myocardial infarction. Am J Cardiol. 2008;102:115-9.
96. Alexander KP, Chen AY, Want TY, et al. Transfusion practice and outcomes in non- ST-segment elevation acute coronary syndromes. Am Heart J. 2008;155:1047-53.
97. Hebert PC, Blajchman MA, Cook DJ, et al. Do blood transfusions improve outcomes related to mechanical ventilation? Chest. 2001;119:1850-7. (Pubitemid 32744945)
98. Levy MM, Abraham E, Zilberberg M, et al. A descriptive evaluation of transfusion practices in patients receiving mechanical ventilation. Chest. 2005;127:928-35. (Pubitemid 40775526)
99. Couture DE, Ellegala DB, Dumont AS, Mintz PD, Kassell NF. Blood use in cerebrovascular neurosurgery. Stroke 2002;33:994-7. (Pubitemid 34293581)
100. Erratum in Stroke 2002;33:1442).
101. Le Roux P, Elliott JP, Winn HR. Blood transfusion during aneurysm surgery. Neurosurgery. 2001;49:1068-75. (Pubitemid 32995843)
102. de Gray LC, Matta BF. The health economics of blood use in cerebrovascular aneurysm surgery: The experience of a UK centre. Eur J Anaesthesiol. 2005;22:925-8. (Pubitemid 41735963)
103. McIntyre L, Hebert PC, Wells G, et al. Is a restrictive transfusion strategy safe for resuscitated and critically ill trauma patients? J Trauma. 2004;57:563-8. (Pubitemid 39313839)
104. Carlson AP, Schermer CR, Lu SW. Retrospective evaluation of anemia and transfusion in traumatic brain injury. J Trauma. 2006;61(3):567-71. (Pubitemid 44400932)
105. Duane TM, Mayglothling J, Grandhi R, et al. The effect of anemia and blood transfusions on mortality in closed head injury patients. J Surg Res. 2008;147:163-7.
106. Salim A, Hadjizacharia P, DuBose J, et al. Role of anemia in traumatic brain injury. J Am Coll Surg. 2008;207:398-406.
107. Mayer SA, Lin J, Homma S, et al. Myocardial injury and left ventricular performance after subarachnoid hemorrhage. Stroke. 1999;30:780-6. (Pubitemid 29156368)
108. Shimojyo S, Scheinberg P, Kogure K, Reinmuth OM. The effects of graded hypoxia upon transient cerebral blood flow and oxygen consumption. Neurology. 1968;18:127-33.
109. Stein S, Levine J, Nagpal S, Le Roux P. Vasospasm as the sole cause of cerebral ischemia: How strong is the evidence? Neurosurg Focus. 2006;21:E1-7.
110. Pluta RM, Zhang J, Dreier J, et al. Cerebral vasospasm after subarachnoid hemorrhage: Time for a new world of thought. Neurol Res. 2009;31:151-8.
111. Stevens RD, Naval NS, Mirski MA, Citerio G, Andrews PJ. Intensive care of aneurysmal subarachnoid hemorrhage: An international survey. Intensive Care Med. 2009;35:1556-66.
112. KramerAH,DiringerMN, Suarez JI,NaidechAM,Macdonald RL, Le Roux P. Red blood cell transfusion in aneurysmal subarachnoid hemorrhage patients: A multidisciplinary North American survey. Neurocritical Care Society Meeting, San Francisco, CA, 2010. Available at http://www.neurocriticalcare.org/i4a/pages/ index. cfm?pageid=3719. Accessed April 2011.